Alnylam Pharmaceuticals
(ALNY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -57,649 | -43,346 | -30,109 | -16,285 | -43,515 |
| Depreciation Amortization | 5,125 | 3,888 | 2,626 | 1,339 | 4,941 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 10,742 |
| Accounts receivable | 1,982 | 1,423 | 2,142 | 2,300 | 2,594 |
| Accounts payable and accrued liabilities | -3,512 | -3,826 | -1,363 | -3,512 | -3,177 |
| Other Working Capital | -55,928 | -38,584 | -16,095 | 3,309 | -79,560 |
| Other Operating Activity | 22,914 | 18,536 | 9,915 | 6,544 | 23,634 |
| Operating Cash Flow | $-87,068 | $-61,909 | $-32,884 | $-6,305 | $-84,341 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 83,250 | 61,942 | 25,426 | 22,315 | 22,570 |
| PPE Investments | -1,291 | -767 | -502 | -28 | -4,732 |
| Investing Cash Flow | $81,959 | $61,175 | $24,924 | $22,287 | $17,838 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 738 | 471 | 471 | 9 | 3,663 |
| Financing Cash Flow | $738 | $471 | $471 | $9 | $3,663 |
| Exchange Rate Effect | N/A | N/A | N/A | N/A | -29 |
| Beginning Cash Position | 74,599 | 74,599 | 74,599 | 74,599 | 137,468 |
| End Cash Position | 70,228 | 74,336 | 67,110 | 90,590 | 74,599 |
| Net Cash Flow | $-4,371 | $-263 | $-7,489 | $15,991 | $-62,869 |
| Free Cash Flow | |||||
| Operating Cash Flow | -87,068 | -61,909 | -32,884 | -6,305 | -84,341 |
| Capital Expenditure | -1,291 | -767 | -502 | -28 | -4,732 |
| Free Cash Flow | -88,359 | -62,676 | -33,386 | -6,333 | -89,073 |